Celsion Corporation Stock Nasdaq
Equities
US15117N4043
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
02:30pm | IMUNON, Inc. Announces First Participants Vaccinated in IMNN-101 Phase 1 Clinical Trial | CI |
May. 20 | Imunon, Inc. Announces CFO Changes, Effective from June 1, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 12.5M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -25M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.64
x | P/E ratio 2025 * |
-0.81
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.85% |
Latest transcript on Celsion Corporation
Managers | Title | Age | Since |
---|---|---|---|
Stacy Lindborg
CEO | Chief Executive Officer | 53 | 21-06-03 |
Michael Tardugno
CHM | Chairman | 73 | 07-01-02 |
Sebastien Hazard
CTO | Chief Tech/Sci/R&D Officer | 53 | Dec. 10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 21-06-07 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 11-07-07 |
James Dentzer
BRD | Director/Board Member | 57 | 22-09-02 |
1st Jan change | Capi. | |
---|---|---|
+18.68% | 123B | |
+15.06% | 107B | |
-4.03% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-12.95% | 16.23B | |
+2.90% | 13.43B | |
+24.74% | 11.32B |